NBF-234

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNBF-234
Drug Alias NameNBF-234
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstra Arcus AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstra Arcus AB
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A